Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls

摘要

Background: Collection of cerebrospinal fluid (beta (A beta) species is a gold standard in Alzheimer's disease (AD) diagnosis, but has risks. Thus, establishing a low-risk blood A beta test with high AD sensitivity and specificity is of outmost interest.